Literature DB >> 11855631

Critical involvement of CD40 in protection against herpes simplex virus infection in a murine model of genital herpes.

K Inagaki-Ohara1, T Kawabe, Y Hasegawa, N Hashimoto, Y Nishiyama.   

Abstract

We studied the requirement for CD40+ cells in the resolution of vaginal infection with avirulent herpes simplex virus type I (HSV-1) in vivo using CD40-deficient mice, which were susceptible to infection with avirulent HSV-1. Compared with wild-type mice, CD40-deficient mice could not eliminate HSV-1 virus effectively from the vaginal mucosa and produced lower amounts of interleukin-12 and interferon-gamma. These results show that the induction and activation of CD40+ cells are important for HSV prevention, facilitating the activation of T cells to induce an efficient HSV clearance from the vaginal mucosa and to prevent lethal illness due to HSV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11855631     DOI: 10.1007/s705-002-8311-3

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  3 in total

1.  Rescue of CD8 T cell-mediated antimicrobial immunity with a nonspecific inflammatory stimulus.

Authors:  Roman A Tuma; Rielle Giannino; Patrick Guirnalda; Ingrid Leiner; Eric G Pamer
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

2.  Mechanism of reduced T-cell effector functions and class-switched antibody responses to herpes simplex virus type 2 in the absence of B7 costimulation.

Authors:  Lydia G Thebeau; Lynda A Morrison
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2.

Authors:  Christian Klemann; Nadezhda Camacho-Ordonez; Linlin Yang; Zoya Eskandarian; Jessica L Rojas-Restrepo; Natalie Frede; Alla Bulashevska; Maximilian Heeg; Moudjahed Saleh Al-Ddafari; Julian Premm; Maximilian Seidl; Sandra Ammann; Roya Sherkat; Nita Radhakrishnan; Klaus Warnatz; Susanne Unger; Robin Kobbe; Anja Hüfner; T Ronan Leahy; Winnie Ip; Siobhan O Burns; Manfred Fliegauf; Bodo Grimbacher
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.